APA (7th ed.) Citation

FT, R., F, J., R, O., A, L., F, H., L, B., . . . M, F. (2017). Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit Study. The oncologist, 22(9), 1117. https://doi.org/10.1634/theoncologist.2017-0047

Chicago Style (17th ed.) Citation

FT, Roncolato, et al. "Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit Study." The Oncologist 22, no. 9 (2017): 1117. https://doi.org/10.1634/theoncologist.2017-0047.

MLA (9th ed.) Citation

FT, Roncolato, et al. "Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit Study." The Oncologist, vol. 22, no. 9, 2017, p. 1117, https://doi.org/10.1634/theoncologist.2017-0047.